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In normal circumstances, the Bcl-2 family dutifully
governs when cells die. However, the rules of en-
gagement between the pro- and antiapoptotic family
members are still contested, and how Bax is trans-
formed from a cytosolic monomer to an outer mito-
chondrial membrane-permeabilizing oligomer is un-
clear. With fluorescence techniques and an in vitro
system, the combination of tBid and Bax produced
dramatic membrane permeabilization. The mem-
brane is not a passive partner in this process beause
membranes are required for the protein-protein inter-
actions to occur. Simultaneous measurements of
these interactions revealed an ordered series of
steps required for outer membrane permeabilization:
(1) tBid rapidly binds to membranes, where (2) tBid
interacts with Bax, causing (3) Bax insertion into
membranes and (4) oligomerization, culminating in
(5) membrane permeabilization. Bcl-XL prevents
membrane-bound tBid from binding Bax. Bad re-
leases tBid from Bcl-XL, restoring both tBid binding
to Bax and membrane permeabilization.
INTRODUCTION
The Bcl-2 family of proteins function as central regulators of ap-
optosis in mammals and includes proteins that both up- and
downregulate apoptosis. Most evidence suggests that the small
regions with similar amino acid sequences shared between fam-
ily members, referred to as Bcl-2 homology regions 1–4 (BH re-
gions) mediate direct interactions between family members and
that these interactions are critical to how the proteins function.
The multi-BH region proteins, Bax and Bak, control commitment
to apoptosis by regulating mitochondrial outer membrane per-
meabilization (MOMP) (Wei et al., 2001). Despite extensive
study, how the Bcl-2 family proteins regulate MOMP remains
speculative (Chipuk and Green, 2008). In some systems, activa-1074 Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc.tion of Bax for MOMP depends on proapoptotic proteins like
PUMA, Bim, or a truncated fragment of Bid (tBid) that are similar
only in that they contain a BH3 region (Kim et al., 2006). Direct in-
teractions of both tBid and Bim with Bax have been reported
(Marani et al., 2002), and they formed the basis for the ‘‘direct ac-
tivation’’ model, in which BH3-only proteins activate Bax and/or
Bak, leading to MOMP. In this model, a complex network of sen-
sitizer and inhibitor proteins that act on different family members
adds an additional level of regulation (Certo et al., 2006). How-
ever, a competing model suggests that a fraction of the Bax in
cells is constitutively active but held in check by binding to anti-
apoptotic Bcl-2 family proteins (Willis et al., 2007). In this ‘‘indi-
rect activation’’ model, BH3-only proteins function exclusively
by binding to antiapoptotic Bcl-2 proteins, releasing Bax, and
the importance of direct activation of Bax by BH3 proteins is dis-
counted. However, both tBid and Bax independently interact
with and undergo conformational changes at membranes (Wei
et al., 2001; Yethon et al., 2003), and membrane-bound Bax
has been reported to recruit cytoplasmic Bax to membranes
(Tan et al., 2006). The importance of these interactions is empha-
sized in the ‘‘embedded together’’ model, which also includes
features of both the direct and indirect activation models (Leber
et al., 2007). Because there are few direct experimental data for
the interactions of these proteins in membranes and a paucity of
kinetic data, the relative importance, order, and mechanism(s) of
many of these interactions remain unknown.
It has long been recognized that multiregion Bcl-2 proteins
share structural features with a-helical pore-forming proteins;
nevertheless, no consensus has emerged for the molecular
mechanism of membrane permeabilization. For Bax, the process
involves at least three steps: migration to membranes, insertion
into the lipid bilayer, and oligomerization. However, the order of
these events is unsettled. Indeed, a priori, there is no reason why
the events leading to MOMP need occur in a specific order. Al-
though it is generally agreed that BH3-only proteins promote
Bax-mediated membrane permeabilization, the underlying
mechanism(s) remains contentious. Experiments using soluble
protein domains and peptides have failed to demonstrate
productive interactions between BH3-only proteins and Bax
(Willis et al., 2007), whereas in other studies, membrane
permeabilization in cells, isolated mitochondria, or liposomes by
full-length Bax usually depends upon addition of either a BH3
protein or peptide (Kuwana et al., 2002; Billen et al., 2008). An
important difference between these experimental approaches
is inclusion in the latter of a lipid bilayer in the form of a liposome
or isolated cellular membrane. Thus, the minimum components
required in vitro for membrane permeabilization include Bax, an
activator protein, and a lipid membrane. Multiple approaches
have been used to unravel the mechanism of Bax activation, in-
cluding surface plasmon resonance (Kim et al., 2005), glycosyl-
ation mapping (Garcı´a-Sa´ez et al., 2004), and mutagenesis
(Wang et al., 1998). However, during the course of Bax activa-
tion by BH3 proteins such as tBid, it is still not known whether
(1) membrane binding plays a role in tBid function, (2) Bax acti-
vation occurs in the cytosol or at the membrane, and (3) the pu-
tative direct interaction between tBid and Bax is essential for
MOMP. To examine the molecular mechanism by which Bax
permeabilizes membranes requires a system in which the indi-
vidual molecular events can be analyzed in isolation. For this
reason, cell-free systems are useful to allow individual interac-
tions of the relevant proteins to be examined with greater clarity
(Basanez and Hardwick, 2008). Cell-free systems recapitulate
the characteristic Bax traits observed in apoptotic cells—
namely, Bax migration to membranes (Wolter et al., 1997) and
oligomerization (Antonsson et al., 2001). Since it is not clear
that all of the interacting components have been identified,
rather than use isolated mitochondria and cell extracts we
used purified proteins and liposomes. The use of a purified sys-
tem allows the core mechanism to be addressed while avoiding
complications from other known and unknown proteins, metab-
olites, and posttranslational modifications that may contribute
additional levels of regulation. To ensure that our system reports
as authentically as possible on the different protein-protein and
protein-membrane interactions that result in membrane perme-
abilization, we used full-length wild-type proteins or functional
single cysteine mutants of Bax. We attached low molecular
weight fluorescent dyes to either endogenous or engineered
cysteine residues in proteins or within the acyl chains of the
lipids to follow molecular interactions using Fo¨rster resonance
energy transfer (FRET), or by measuring changes in the spectral
properties of the dyes reflective of changes in the hydrophobic-
ity of their environment. In this way, it was possible both to
recapitulate Bax-mediated membrane permeabilization and to
measure in real time the various protein-protein and protein-
membrane interactions involved.
Our results suggest that membrane permeabilization depends
upon an ordered series of conformation changes and protein-
protein and protein-membrane interactions initiated by mem-
brane binding of tBid. Conformational changes in both tBid
and Bax resulting from their interaction with membranes greatly
increase the rate and extent of tBid-Bax binding. Moreover, the
direct binding of tBid to Bax occurs on the membrane and is fol-
lowed by integration of Bax into the bilayer and recruitment of
additional Bax. Subsequent oligomerization of Bax results in
the formation of pores in membranes, with substoichiometric
quantities of tBid remaining associated with the pore and Bax
oligomerization continuing even after membranes are permeabi-
lized. Bcl-XL inhibits the process by binding to and sequesteringmembrane-bound tBid. Bad releases tBid from Bcl-XL and the
released tBid molecules bind to and activate Bax.
RESULTS AND DISCUSSION
To quantify membrane permeabilization, we measured the re-
lease of four fluorescent molecules encapsulated together in li-
posomes. Because each of the molecules has distinct excitation
and emission spectra, it was possible to measure the release of
all four molecules in the same samples. The encapsulated
molecules included both low molecular weight compounds (me-
thoxypyrenetrisulfonic acid trisulfonate [MPTS], 0.45 kDa, and
fluorescein conjugated dextran, 3 kDa) and large fluorescent
proteins (allophycocyanin [APC], 100 kDa, and B-phycoerythrin
[BPE], 250 kDa). As expected, when the membranes were intact,
the encapsulated molecules cofractionated with the liposomes
in the excluded volume by Sepharose CL-2B gel filtration chro-
matography (Figure 1A, fractions 1–7). After incubation with
20 nM tBid and 200 nM Bax, the fluorescent molecules were re-
leased from liposomes and, therefore, eluted in later fractions
(Figure 1A, right panel, fractions 8–22). During gel filtration chro-
matography, the released fluorescent dextran eluted in earlier
fractions than expected on the basis of the molecular weight of
the polymer, presumably because of some nonspecific binding
of the dextran to the liposomes (Heuck et al., 2003). However,
this released fraction and that of the large proteins (fractions
8–15) were still clearly resolved from intact liposomes (fractions
1–7). Fluorescence spectroscopy was used to quantify the differ-
ent fluorophores in each of the fractions for three experiments
(Figure 1B). Liposomes were not permeabilized by 200 nM Bax
(Figure 1B) or 20 nM tBid alone (data not shown). When both
tBid and Bax were present, release of all four fluorophores in-
creased as the concentration of Bax increased from 25 nM to
200 nM. Thus, in incubations containing tBid, Bax, and mem-
branes in proportions roughly similar to those seen in cells, the
two proteins permeabilized liposomes and released proteins
as large as 250 kDa. This assay clearly demonstrates that tBid
and Bax are sufficient to permeabilize liposome membranes.
Similar to observations in cells, tBid activates Bax to bind to
and permeabilize membranes in vitro (Kuwana et al., 2002; Billen
et al., 2008). However, it is unclear whether membrane binding of
Bax and Bax oligomerization to form pores are coordinated or
separately regulated processes, or whether the reaction pro-
ceeds as an ordered series of events or stochastically. When
Bax binding to membranes and oligomerization was measured
by gel exclusion and gel filtration chromatography, respectively
(Figure S1 available online), the experiments provided rather
poor temporal resolution. Although consistent with Bax mem-
brane binding preceding Bax oligomerization, these data cannot
rule out a stochastic process in which both processes occur
concurrently. Furthermore, oligomerization and membrane per-
meabilization cannot be directly correlated via this approach.
The formation of detergent-resistant oligomers provides only
an indirect measure of Bax-Bax interactions in membranes,
and the detergents required to solubilize the membrane may
have unanticipated effects on protein-protein interactions.
Crosslinking has been used as an independent method to as-
sess interactions of these proteins, although the temporalCell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc. 1075
resolution is even more problematic (Billen et al., 2008). There-
fore, to observe these events in real time, we examined tBid-
Bax and Bax-Bax interactions and the interactions of these
proteins with membranes by fluorescence techniques.
Bax Binds tBid Only if Membranes Are Present
Binding of Bax to tBid was examined with FRET between dime-
thylaminocoumarin (DAC)-labeled tBid and 7-nitrobenzene-2-
oxa-1, 3-diazol-4-yl ethylenediamine (NBD)-labeled Bax. For
these experiments murine tBid was labeled on the one endoge-
nous cysteine (residue number 126 of Bid) with DAC; this protein
was designated DAC-tBid. DAC is a blue-emitting coumarin de-
rivative that is a good energy transfer donor for the acceptor dye
NBD (Fo¨rster radius 5 nm). As an acceptor, a single cysteine
version of Bax was constructed by changing cysteine 62 to ala-
nine, and the protein was labeled on the remaining endogenous
cysteine (position 126) with NBD; this protein was designated
Figure 1. Bax and tBid Are Jointly Required for the Permeabilization
of Liposomes
(A) Chromatograms from gel filtration columns of liposome encapsulated fluo-
rophores of various sizes (MPTS [0.45 kDa], blue; fluorescein dextran [3 kDa],
green; APC [100 kDa], red; BPE [250 kDa], yellow). All four fluorophores were
encapsulated in the same liposomes and remained encapsulated when incu-
bated with Bax (left panel) but were released from liposomes incubated with
tBid and Bax (right panel). Superposition of the curves in the left panel results
in only the yellow curve being visible for the main peak. Liposomes eluted in the
excluded fractions (1–7) while released proteins separated in the included frac-
tions (8–21).
(B) Release of fluorophores from liposomes quantified for three experiments
such as those shown in (A) demonstrates that membrane permeabilization in-
creases with increasing concentrations of Bax and releases proteins of up to
250 kDa. Error bars indicate the standard deviation, n = 3.1076 Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc.NBD-126-Bax. After they were labeled, both proteins retained
similar activity to the unlabeled, wild-type proteins in a dye re-
lease assay for membrane permeabilization (Figure S2). As
a negative control, tBid with a mutation in the BH3 region, tBid
G94E, previously shown not to bind Bax (Wang et al., 1996),
was substituted for DAC-tBid. As expected, when incubated
with Bax and liposomes, neither tBid G94E nor DAC-tBid G94E
induced significant dye release (Figure S2).
When DAC-tBid (20 nM) and NBD-126-Bax (100 nM) were in-
cubated together, energy transfer (detected as a decrease in do-
nor fluorescence) was observed only if membranes (2.5 nM
liposomes) were also present (Figure 2A), suggesting that the
two proteins interact only when bound to membranes. Consis-
tent with this interpretation, substitution of DAC-tBid G94E for
DAC-tBid significantly (p < 0.05) reduced the energy transfer
with NBD-126-Bax. However, although both DAC-tBid and the
DAC-tBid G94E point mutant bound membranes very efficiently
(see below), DAC-tBid G94E did not trigger the membrane inser-
tion of NBD-126-Bax (data not shown). It therefore remains pos-
sible that the FRET we observed between DAC-tBid and NBD-
126-Bax was due to their proximity in the membrane bilayer
rather than resulting from a specific interaction. To address
this possibility, we added 50 mM Bid BH3 peptide to NBD-126-
Bax and liposomes prior to the addition of either DAC-tBid
G94E or DAC-tBid. At these concentrations, the Bid BH3 peptide
has been shown to trigger insertion of Bax into membranes (Hen-
derson et al., 2007) and result in membrane permeabilization
(data not shown).
The minimal FRET observed between DAC-tBid G94E and
NBD-126-Bax was not affected by preincubation with Bid BH3
peptide, suggesting that proximity in the membrane bilayer itself
does not account for the FRET observed between DAC-tBid and
NBD-126-Bax. The residual FRET may instead be due to residual
binding between the proteins not detected by coimmunoprecipi-
tation. However, if that was the case, then we would expect the
FRET to be further reduced by the addition of excess BH3 pep-
tide, which would compete with DAC-tBid G94E for binding to
Bax. Consistent with direct binding between DAC-tBid and
NBD-126-Bax, addition of the Bid BH3 peptide reduced the en-
ergy transfer between DAC-tBid and NBD-126-Bax (Figure 2B).
Taken together, these results confirm that the FRET observed
between DAC-tBid and NBD-126-Bax resulted from a specific
interaction in the membrane bilayer and was not due merely to
proximity based on their colocalization.
The extent of energy transfer between DAC-tBid and NBD-
126-Bax did not decrease over time (Figure 2A), suggesting
that at steady state some fraction of tBid remained bound to
Bax in the lipid membrane. This result was unexpected given
that tBid and Bax do not cofractionate when liposomes or mito-
chondria are solubilized with the detergent CHAPS (Billen et al.,
2008). Unlike nonionic detergents such as Triton X-100, CHAPS
does not artificially promote interactions between Bcl-2 family
proteins (Hsu and Youle, 1997). When 2% CHAPS was added
to the incubations containing tBid, Bax, and liposomes, it re-
duced the interaction between tBid and Bax measured by
FRET (Figure 2B, +det.). Thus, although tBid bound Bax in mem-
branes, most of the heteromers dissociated when the membrane
was solubilized with CHAPS.
Figure 2. tBid Binding to Bax Requires Membrane
(A) DAC-tBid (20 nM) fluorescence decreases because of FRET with NBD-126-
Bax (100 nM) only when liposomes (125 mM lipid) are present. In incubations
without the NBD acceptor on Bax or without added liposomes, the fluores-
cence of DAC-tBid does not decrease. F/Fo is the fluorescence at the indi-
cated time divided by the fluorescence at time zero.
(B) FRET was measured from pairs of reactions containing liposomes (125 mM
lipid), 20 nM DAC-tBid (tBid), or DAC-tBid G94E (G94E) with either unlabeled
100 nM Bax to measure fluorescence of the donor (FD) or 100 nM NBD-126-
Bax to measure fluorescence of the donor with acceptor (FD+A). FRET effi-
ciency (1-FD+A/FD) was quantified after incubation for 30 min. BH3 peptide:
50 mM Bid BH3 peptide was used to trigger Bax to insertion into the liposome
membrane for 2 hr prior to the addition of DAC-tBid. The addition of 2%
CHAPS at the end of the incubation (+det.) reduces tBid binding to Bax mea-
sured as FRET between DAC-tBid and NBD-126-Bax. Error bars indicate the
standard error, n = 8–12. The FRET efficiency for DAC-tBid and NBD-126-Bax
was significantly higher (p < 0.05, ANOVA) than that for any of the other sam-
ples. There were no significant differences between the other samples.Detection of FRET between DAC-tBid and NBD-126-Bax at
steady state allowed examination of the concentration depen-
dence of the interaction at equilibrium. As expected for an au-
thentic interaction, binding of NBD-126-Bax to DAC-tBid was
saturable (Figure 2C). The decrease in DAC-tBid fluorescence
in samples prepared containing different amounts of NBD-126-
Bax was fit with a single exponential, resulting in an apparent
Kd of 20 nM. This value must be interpreted with caution be-
cause there are a number of underlying assumptions for which
there is no evidence, including that the interaction is bimolecular
and that the subunits are exchangeable. As a partial test of the
latter assumption, samples were prepared in which the total
amount of Bax was 150 nM but the amount of NBD-126-Bax var-
ied (Figure 2D). Consistent with the subunits being exchange-
able, the resulting binding data fit better to a straight line than
to an exponential decay. Although the r2 value for the linear fit
was only 0.95, there was too much variation within the data
(note that the error bars are standard error for n = 7–9) to justify
more sophisticated curve fitting. Taken together, these data
strongly suggest that when bound to membranes there is a direct
but reversible binding interaction between tBid and Bax.
tBid Binds to Membranes Rapidly
Our results suggest that interaction of tBid and/or Bax with the
membrane is prerequisite for heterodimerization. Because tBid
and Bax have each been reported to interact with membranes in-
dependently in a variety of systems, we examined each putative
interaction separately. To measure tBid binding to liposomes,
we incubated DAC-tBid with liposomes labeled by including
0.5% w/w 1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)
amino]dodecanoyl]-sn-Glycero-3-Phosphoethanolamine (NBD-
PE). Comparison of the DAC fluorescence for DAC-tBid bound
to liposomes with and without NBD-labeled lipids revealed
energy transfer between DAC-tBid and NBD-labeled lipids
(Figure 3A). Most of the decrease in DAC fluorescence occurred
within the first 4–6 s required to add and mix the tBid into the re-
action therefore fluorescence of the DAC-tBid donor alone (FD)
was estimated from a parallel incubation without NBD-labeled
lipids. All of the tBid in the incubation bound to liposomes suffi-
ciently tightly that it was recovered in membrane-containing
fractions after gel filtration chromatography (data not shown).
Therefore, it was possible to use the decrease in DAC fluores-
cence and the amount of labeled tBid in the reaction to calculate
that during the first 10 s of incubation, the rate at which tBid
bound to membranes was at least 1012 molecules/s. As a control
for random collisions between the fluorescently labeled protein
and membranes, we repeated the reaction with DAC-HisBid
(C) Binding of NBD-126-Bax to DAC-tBid is saturable. End point assays (2 hr)
are shown for FRET between 20 nM DAC-tBid liposomes (125 mM lipid) and the
indicated concentration of NBD-126-Bax. FRET data (FD+A/FD) were fit to
a simple exponential decay. Error bars indicate the SEM for n = 7–9.
(D) Subunit exchange in complexes of DAC-tBid and NBD-126-Bax. Binding
between 20 nM DAC-tBid liposomes (125 mM lipid) and the indicated concen-
tration of NBD-126-Bax were allowed to come to equilibrium (2 hr) as in (C),
and then unlabeled Bax was added to bring the final concentration of Bax to
150 nM. FRET between DAC-tBid and NBD-126-Bax was measured as in
(C). The data were fit with a straight line of best fit. Error bars indicate the
SEM for n = 7–9.Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc. 1077
instead of DAC-tBid. Full-length Bid does not bind tightly to
membranes, and consequently no significant FRET was ob-
served between the DAC-HisBid and NBD liposomes
(Figure 3A). Taken together, these results demonstrate that
tBid binding to liposomes is very rapid. Finally, this assay was
also used to demonstrate that the G94E mutation in tBid did
not alter DAC-tBid-G94E binding to membranes (Figure S3).
In contrast with tBid, published data suggest that Bax inter-
acts only weakly with liposome membranes (Yethon et al.,
2003) and mitochondria (Billen et al., 2008) unless it is activated.
Although transient, the interaction results in a change in the con-
formation of Bax that can be detected with a conformation-
specific antibody or by crosslinking. Consistent with the low-
affinity and transient nature of the interaction between Bax and
liposomes, only a small amount of FRET was detected between
DAC-labeled Bax and NBD liposomes. However, the interaction
was too small to easily differentiate binding from collisions in so-
lution, making it difficult to estimate either the initial rate or
Figure 3. Binding of tBid to Liposomes and Bax Oligomerization
Measured by FRET
(A) tBid binds to membranes very rapidly. Fluorescence of DAC-tBid or DAC-
HisBid (DAC-Bid) after incubation with liposomes containing NBD-PE (FD+A)
and without NBD-PE (FD) for the indicated time is shown. FD+A/FD is the fluo-
rescence at the indicated time of the donor in incubations containing both do-
nor and acceptor divided by the fluorescence of the donor a similar incubation
without the acceptor. The decrease in FD+A/FD indicates that FRET between
DAC-tBid and NBD-PE in the liposomes resulting from tBid binding to lipo-
somes.
(B) Bax oligomerization measured as FRET between DAC-134-Bax and NBD-
126-Bax. The fluorescence of DAC-134-Bax at the indicated time (F) divided
by the fluorescence of DAC-134-Bax immediately upon addition of NBD-
126-Bax (Fo) is shown for the conditions indicated: without liposomes (no lipo-
somes), with Bax instead of NBD-126-Bax (no acceptor), and with NBD-126-
Bax and DAC-134-Bax (Bax-Bax). Wild-type tBid (20 nM) was present in all
reactions. The decrease in F/Fo indicates FRET due to DAC-134-Bax binding
to NBD-126-Bax.1078 Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc.steady-state fraction of Bax bound to the membrane (data not
shown).
Bax-Bax Interaction
In the presence of membranes, Bax behaves as a monomer by
gel filtration chromatography (Yethon et al., 2003), yet Bax
monomers undergo a conformational change that can be de-
tected via intermolecular crosslinking with DSS (Billen et al.,
2008), suggesting that Bax molecules are frequently in close
enough proximity that the chemical can react with multiple
monomers. However, these approaches (e.g., Figure S1) lack
the temporal resolution to determine where in the sequence of
molecular events leading to membrane permeabilization Bax oli-
gomerizes. To examine this issue by measuring FRET, we la-
beled Bax monomers with either the donor (DAC) or acceptor
(NBD) and then mixed them together.
Energy transfer was not detected for 20 nM DAC-134-Bax and
100 nM NBD-126-Bax in incubations that did not contain lipo-
somes even when tBid was included (Figure 3B). However, fluo-
rescence from DAC-134-Bax decreased slowly in incubations
containing both tBid (20 nM) and liposomes (2.5 nM), consistent
with oligomerization of Bax requiring both an activator and
a membrane (Figure 3B). No change in DAC fluorescence was
observed in control reactions containing DAC-134-Bax, tBid,
and liposomes but containing unlabeled Bax instead of NBD-
126-Bax (Figure 3B, no acceptor), confirming that the decrease
in DAC fluorescence resulted from energy transfer from DAC-
134-Bax to NBD-126-Bax in Bax oligomers.
Membrane Permeabilization Results from a Series
of Ordered Reactions
The FRET data for 20 nM DAC-134-Bax and 100 nM NBD-126-
Bax suggest that Bax oligomerization takes place on a very
different time scale than tBid binding to membranes (compare
Figures 3A and 3B). Thus, the reactions of tBid and Bax may
be ordered rather than occurring stochastically. Although our re-
sults clearly demonstrate that tBid binding to membranes occurs
prior to any of the other interactions that contribute to membrane
permeabilization, ordering the other steps from separate exper-
iments is less certain. The fraction of tBid bound to Bax in mem-
branes at equilibrium is not known. Similarly, the fraction of Bax
undergoing FRET at the end of the incubation is unknown. There-
fore, it was not possible to calculate absolute values for the rates
of tBid-Bax or Bax-Bax oligomerization. To examine the order of
events in more detail, we established an assay in which it was
possible to make three measurements from a single incubation.
As shown schematically, in one incubation, tBid binding to Bax
(Figure 4A, I), Bax insertion into membranes (Figure 4A, II) and
membrane permeabilization (Figure 4A, IV) were measured. In
another incubation Bax-Bax interaction (Figure 4A, III), Bax inser-
tion into membranes and membrane permeabilization were
measured.
Measuring multiple events in a single sample was feasible by
selecting appropriate fluorophores and optimizing selection of
excitation and emission wavelengths. DAC fluorescence was
measured by excitation at 380 nm and emission at 460 nm, leav-
ing most of the visible spectrum available for additional fluores-
cence measurements. The fluorescent dye NBD is not only
Figure 4. tBid Binding toMembranes Initiates an Ordered Series of Conformational Changes Leading toMembrane Permeabilization by Bax
(A) Fluorescence-based assays for tBid binding to Bax (I), Bax inserting into the membrane (II), Bax oligomerization (III), and membrane permeabilization (IV).
Excitation (Ex) and emission (Em) wavelengths are indicated in nm.
(B) Time courses for tBid binding to Bax (cyan), membrane permeabilization (green), and Bax insertion into membranes (orange) expressed as a fraction of the
maximal change for incubations containing the indicated components.
(C) Time courses for membrane permeabilization (green), Bax insertion into membranes (orange), and Bax oligomerization (purple) expressed as a fraction of the
maximal change for incubations containing the indicated components.
(D and E) Time to 50% completion for the indicated reactions quantified for three replicates of the experiments in (B) and (C), respectively.
(F) Initial rates of the reactions in (B) normalized to the maximum rate for each.
(G) Relative initial rates for the first 15 s for the reactions in (B).
Error bars in (D), (E), and (G) indicate the standard deviation, n = 3.Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc. 1079
a good acceptor for DAC fluorescence, but it can also be used to
monitor insertion of a protein into a lipid bilayer because the fluo-
rescence intensity of NBD increases when the dye moves to
a more hydrophobic environment (Shepard et al., 1998). The
two measurements can be made in the same incubation be-
cause the absorbance of NBD at wavelengths shorter than
480 nm that are critical for energy transfer from DAC is minimally
affected by the environment of the dye. Insertion of Bax into the
membrane was monitored by illuminating the sample at 475 nm
and measuring the increase in fluorescence emission of the
NBD-126-Bax at 530 nm. Finally, liposome permeabilization
was measured by loading liposomes with a terbium-dipicolinic
acid complex. This highly fluorescent complex (excitation
280 nm, emission 490 nm selected to minimize interference be-
tween the assays) is efficiently quenched by chelating the ter-
bium with EDTA. Because the EDTA was added to the medium
outside the liposomes, membrane permeabilization was re-
quired for the EDTA to chelate the terbium and quench the fluo-
rescence (Heuck et al., 2003). Through recording of all three
measurements every 15 s, it was possible to follow three reac-
tions in a single incubation over the same time course (Figure 4).
After the terbium-dipicolinic acid complex is encapsulated,
the liposomes must be separated from the nonencapsulated
dye by gel filtration chromatography. As a result, the concentra-
tion of liposomes is difficult to control precisely, and it is both
lower and more variable in these reactions than in those de-
scribed above (Figures 2 and 3). Moreover, the total amount of
Bax used in the experiment in Figure 4B is less than that in the
experiment in Figure 4C. For all of these reasons, the absolute
values of the reactions cannot be compared between indepen-
dent experiments. However, the relative ordering of reactions
within a single incubation is accurate both qualitatively and
quantitatively.
To facilitate visual comparison of the data, we show changes
in fluorescence (energy transfer from DAC to NBD, fluorescence
increase for NBD, and fluorescence decrease for terbium dipico-
linic acid) as a fraction of the maximal change. In this way, each
reaction was scaled between 0 (the starting point) and 1 (the end
point). When this approach was used to examine tBid binding to
Bax, Bax insertion into the membrane, and membrane permea-
bilization, it appeared that tBid bound to Bax as a separate step
that occurred prior to either Bax insertion into the membrane or
membrane permeabilization (Figure 4B). This was assessed
quantitatively by comparison of the t1⁄2 for the reactions for three
replicates of the experiment (Figure 4D). Although Bax continued
to insert into membranes for more than 3000 s (Figure 4B), by this
point, more than 90% of the Bax added to the reaction had em-
bedded in the membrane (data not shown). The amount of time
required for the last 10% of the NBD-126-Bax to insert into mem-
branes does not affect the t1⁄2 of the reaction.
In multiple independent experiments, the t1⁄2 for tBid-Bax
FRET was always substantially less than that for Bax insertion
into membranes or membrane permeabilization. These results
are consistent with tBid binding to Bax being a separate step
that occurs prior to insertion of Bax into membranes. However,
in our experimental system, 20 nM tBid results in almost com-
plete insertion of 100 nM Bax (Figure S1A) and as shown in Fig-
ure 2, some fraction of tBid remains bound to Bax in the liposome1080 Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc.membrane. Another explanation for these data is that once Bax
inserts into membranes, the membrane-bound Bax continues to
recruit soluble Bax to the membrane, thereby extending the half-
time for insertion of Bax into membranes. It is therefore possible
that binding of tBid to Bax may occur at the same time as inser-
tion of the tBid bound Bax into the membrane, while the integra-
tion into membranes of soluble Bax recruited by membrane
bound Bax (or the tBid-Bax complex) occurs afterwards. To min-
imize the potentially confounding effect of Bax recruiting Bax to
the membrane on the measured t1⁄2 of the reaction and further re-
solve the order of events, we compared the initial rates for the
relevant reactions (Figures 4F and 4G, described in more detail
below).
In complementary but independent experiments in which Bax-
Bax FRET was measured, both membrane permeabilization and
insertion of Bax into the membrane were accelerated compared
to Figure 4B. As noted above, there may be several reasons for
this variability. Nevertheless, the ordering of the two processes
was the same in multiple independent experiments, and Bax-
Bax FRET always tracked with or slightly behind Bax insertion
into membranes. As a result, the t1⁄2 for Bax insertion into the
membrane was less than that for Bax-Bax FRET (Figure 4E).
These data strongly suggest that the interaction that results in
FRET between DAC-134-Bax and NBD-126-Bax occurs shortly
after Bax inserts into membranes. Thus, at least one step in the
Bax oligomerization process occurs after Bax inserts into
membranes.
Ordering the individual steps from the data in Figures 4B and
4C relative to membrane permeabilization is complicated be-
cause quenching of the terbium dipicolinic acid complexes be-
gins and ends before Bax-Bax binding has come to equilibrium
and before all of the Bax has inserted into membranes. Neverthe-
less, visual inspection of the change in DAC-tBid fluorescence
due to FRET with NBD-126-Bax compared to quenching of ter-
bium-dipolinic acid suggested that tBid binds to Bax much more
rapidly than membrane permeabilization (Figure 4B). This is con-
sistent with the measured t1⁄2 for the reaction and suggests that
tBid-Bax binding is not rate limiting in membrane permeabiliza-
tion. It may seem counterintuitive that the t1⁄2 for membrane per-
meabilization is less than that for either Bax insertion into mem-
branes or oligomerization. However, it is likely the result of Bax
continuing to insert into and oligomerize in the bilayer of lipo-
somes that have already been permeabilized. Our assay mea-
sures only the initial permeabilization of each liposome, because
once the terbium-dipicolinic acid has been released, subsequent
permeabilization events in that liposome cannot be detected.
Therefore, to compare the relative rates of the different interac-
tions with membrane permeabilization, we measured them at
early times, when the contribution of further oligomerization
‘‘events’’ on the overall rate of the reaction could be neglected.
When initial rates are compared (Figures 4F and 4G), it is clear
that during the first 15 s, membrane permeabilization is much
slower than either Bax insertion into membranes or oligomeriza-
tion. This is consistent with models in which more than one Bax
protein must insert into a liposome to permeabilize it.
To permit initial rates to be displayed graphically for all three
interactions, we normalized them such that the maximum rate
for each was set to 1. Although the rate of membrane
permeabilization is shown for the first 1000 s of the incubation, it
is likely that more than half of the permeabilization events occur
in liposomes that have not previously been permeabilized only
prior to the previously measured t1⁄2 of 600 s. Therefore, to follow
changes in permeabilization rates, we considered only the first
300 s of the reaction. Consistent with oligomers of Bax mediat-
ing membrane permeabilization, the rate remained lower than
the maximum rate for more than 150 s. The maximum rate for
permeabilization occurred at the time when tBid-Bax binding
was coming to equilibrium (Figure 4B), suggesting that once
a critical threshold of Bax inserted into the bilayer, permeabiliza-
tion occurred rapidly. As expected, the rate of permeabilization
began to decline prior to the t1⁄2 because Bax continued to accu-
mulate in the membranes of liposomes that had already been
permeabilized and inserted into and permeabilized intact
liposomes.
The examination of initial rates also permits us to determine
whether tBid binds Bax as a separate interaction prior to inser-
tion of Bax into membranes. As above, the change in fluores-
cence during the first 15 s of each reaction was used to estimate
the initial rate. To permit comparison of the initial rates for the dif-
ferent interactions, we expressed each as a fraction of the total
reaction per second. During the first 15 s of the incubation, the
initial rate for Bax insertion into membranes should not be af-
fected by Bax recruiting additional Bax proteins, because the
amount of Bax in the membrane is negligible compared to the
amount of membrane bound tBid (Figure 3). The initial rate
data demonstrate that tBid binding to Bax preceded both inser-
tion of Bax into the membrane and pore formation by Bax
(Figure 4G). The rate of tBid binding to Bax then dropped rela-
tively rapidly (Figure 4F), as expected, since there was much
less tBid (20 nM) in the reaction than Bax (100 nM) and half of
the tBid that binds to Bax at equilibrium was bound in just over
200 s. These results strongly suggest that tBid binding to Bax
is a separate step that precedes insertion of Bax into the bilayer.
Moreover, they suggest that a step subsequent to tBid binding to
Bax is rate limiting for membrane permeabilization.
When the initial rates were compared for Bax-Bax interaction
and Bax insertion into membranes, the difference in the two rates
was smaller than the variation in the rates between independent
experiments. However, in every experiment, Bax oligomerization
occurred relatively rapidly after insertion of Bax into the mem-
brane (e.g., Figure 4C). The simplest explanation for these results
is that insertion of Bax into the lipid bilayer (Figure 4A, step II) is
the rate-limiting step. The identification of this specific change
in Bax as rate limiting for the entire process has important
implications because it suggests that insertion of Bax into the
membrane is a potential therapeutic target. Taken together,
our results indicate that once tBid binds to membranes,
permeabilization proceeds in the order illustrated in Figure 4A
(steps I–IV).
Regulation of tBid-Bax Interactions by Bcl-XL and Bad
We have recently shown that Bcl-XL inhibits Bax-mediated
membrane permeabilization by competing with Bax for binding
to tBid and Bax (Billen et al., 2008). However, for purification of
tBid, the full-length Bid protein was first digested with caspase
8, and then the p7 fragment was separated from the p15 frag-ment with octyl-glucoside. One possible implication of the
need for this detergent-based separation step is that release of
the cBid p7 fragment from the active cBid p15 fragment in cells
is protein mediated and therefore may be tightly regulated, as
proposed previously (Tait et al., 2007; Zha et al., 2000). However,
when assayed both for binding to membranes by FRET and for
triggering Bax to permeabilize liposomes by dye release, His-
tagged cBid was as effective as tBid (Figure S4). Furthermore,
separation of the p7 and p15 fragments of cBid occurred spon-
taneously upon addition of liposomes, as determined by FRET
between each fragment and the membrane (Figure S4). Addition
of DAC-126-cBid (DAC-labeled cBid in which the cysteine in the
p7 fragment was replaced by serine and the endogenous cyste-
ine at position 126 was labeled with DAC) to liposomes resulted
in rapid formation of DAC-126-cBid p15 (data not shown). The
DAC fluorophore is in the same position in DAC-126-cBid as in
the DAC-tBid used above. As expected, DAC-126-cBid trig-
gered Bax-mediated release of liposome contents in a manner
inhibitable by Bcl-XL (Figure S4). Addition of Bcl-XL did not in-
hibit DAC-126-cBid from binding membranes, but it did prevent
it from binding to NBD-126-Bax (Figures S4 and S5). Together,
these results strongly suggest that membrane binding is suffi-
cient to separate the two fragments of cBid, and therefore a sep-
arate cBid activating protein is not required. We conclude, there-
fore, that our cell-free system includes all of the essential core
components for regulating membrane permeabilization.
There are two competing models for the mechanism by which
Bcl-XL prevents membrane permeabilization. In one model, the
primary interaction is sequestration of BH3-only region proteins
such as cBid p15, whereas the other model suggests that Bcl-XL
binds to and inhibits Bax. A prediction of the former model that
distinguishes it from the latter is that BH3 only proteins such as
Bad release cBid p15 from Bcl-XL, and the released cBid p15
molecules then bind to and activate Bax. Although there is sub-
stantial indirect evidence for (and against) this model, it has been
difficult to test directly. In particular, it is not clear whether it is
cBid p15 released from Bcl-XL that activates Bax. Alternatively,
other molecules of cBid p15 might activate Bax, or it might be ac-
tivated some other way. To test the hypothesis that cBid p15
molecules released from Bcl-XL by Bad bind to and activate
Bax directly, we used fluorescence spectroscopy to monitor
binding of DAC-126-cBid to NBD-126-Bax and insertion of
NBD-126-Bax into the bilayer as above. In these assays, it was
possible to visualize both processes in real time from a single in-
cubation directly from the fluorescence traces.
Binding of cBid p15 to Bax was monitored by measuring the
decrease in DAC fluorescence due to FRET when DAC-126-
cBid binds to NBD-126-Bax (Figure 5A), while insertion of
NBD-126-Bax into the liposome membrane was monitored by
the increase in NBD fluorescence that accompanies movement
of the dye to a more hydrophobic environment, which we inter-
pret as insertion of the dye into the lipid bilayer (Figure 5B). Back-
ground fluorescence, primarily due to scatter from the lipsomes,
is seen in both traces prior to the addition of DAC-126-cBid. As
expected, when DAC-126-cBid was added to the reaction, there
was an equivalent large increase in fluorescence (Ex 380 nm/ Em
460 nm) whether or not the incubations also contained Bcl-XL.
Subsequent addition of NBD-126-Bax to the incubations thatCell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc. 1081
did not contain Bcl-XL resulted in a substantial decrease in the
fluorescence of DAC-126-cBid due to FRET resulting from bind-
ing of the two proteins in the membrane (Figure 5A, blue line).
Consistent with DAC-cBid functioning similarly to tBid, the rate
Figure 5. Bcl-XL-Mediated Inhibition of DAC-cBid p15 Binding
to NBD-126-Bax Is Relieved by HBad
DAC-cBid binding to NBD-126-Bax results in FRET detected as decreased
DAC-fluorescence (Ex380/Em460) (A) and insertion of Bax into the membrane
detected as increased NBD-fluorescence (Ex475/Em530) (B). Background
signal was measured for incubations containing liposomes (blue line) or lipo-
somes and 40 nM Bcl-XL (green and red lines), and then the other proteins
were added at the times indicated by the arrows: DAC-cBid (20 nM), NBD-
126-Bax (100 nM), and HBad (400 nM). Unprocessed fluorescence traces
(arbitrary units) are shown for a single experiment representative of three inde-
pendent experiments.1082 Cell 135, 1074–1084, December 12, 2008 ª2008 Elsevier Inc.of change and the extent of FRET was similar to that seen for
DAC-tBid and NBD-126-Bax (Figure 4B). As expected, the inter-
action of DAC-126-cBid and NBD-126-Bax was effectively
blocked by Bcl-XL (Figure 5A, red line). Addition of full-length
His-tagged Bad (HBad) restored binding of DAC-126-cBid to
NBD-126-Bax, as seen by the decrease in DAC fluorescence
over time due to FRET (Figure 5A, green line). At the concentra-
tions of the proteins used here, essentially all of the DAC-126-
cBid p15 bound to Bcl-XL prior to the addition of Bad (Billen
et al., 2008 and data not shown). Therefore, our FRET data dem-
onstrate that the DAC-126-cBid p15 molecules released from
Bcl-XL by HBad proceed to bind to Bax.
Measurements of NBD fluorescence from the same samples
confirmed that binding of DAC-126-cBid to NBD-126-Bax trig-
gered Bax to insert into liposomes (Figure 5B, blue line). How-
ever, when 40 nM Bcl-XL was present in the sample, Bax inser-
tion into the membrane was largely inhibited for 30 min. Addition
of HBad restored Bax insertion into membranes with kinetics
similar to cBid-mediated insertion of NBD-126-Bax in the ab-
sence of Bcl-XL, demonstrating that 400 nM HBad was sufficient
to completely inhibit the function of 40 nM Bcl-XL. However,
even in the absence of Bad, 40 nM Bcl-XL did not completely
prevent insertion of NBD-126-Bax into the bilayer, especially af-
ter extended times (>30 min, Figure 5B), even though membrane
permeabilization was effectively blocked (Figure S4). We pre-
sume that the Bax that inserts into the membrane is bound by
Bcl-XL and thereby prevented from oligomerizing, as seen previ-
ously (Billen et al., 2008). The data shown are from a single ex-
periment representative of three independent experiments
quantified in Figure S6. Taken together, our results establish
that cBid-p15 molecules released from Bcl-XL by HBad rapidly
bind to and activate Bax, causing it to insert into liposome mem-
branes, where Bax then oligomerizes and permeabilizes the
membrane.
In cells and in cell-free reactions, arguably the most abundant
component of the permeabilization process is the membrane.
Nevertheless, the membrane has been generally considered
a passive recipient of Bcl-2 family proteins. The ordered reac-
tions that we have elucidated for tBid initiated Bax-mediated
membrane permeabilization take place primarily in and on the
lipid membrane. Moreover, the membrane contributes actively
to the process by inducing conformation changes in the proteins
requisite for membrane permeabilization.
By reconstituting the entire process of activation, recruitment
to membranes, permeabilization, inhibition by Bcl-XL, and re-
lease from inhibition with Bad, we have demonstrated the func-
tional relationships underlying the core molecular mechanism by
which Bcl-2 family proteins regulate membrane permeabiliza-
tion. We have shown that, contrary to several current models,
the events are regulated by reversible binding interactions with
sufficiently different rates to result in an ordered stepwise mech-
anism. Our results are consistent with a model in which regula-
tion is achieved via modulation of this series of competitive bind-
ing interactions by expression levels, localization, interactions
with other known and unknown proteins, posttranslational mod-
ifications of the proteins, and changes in the lipids in the outer
mitochondrial membrane (Billen et al., 2008, Leber et al.,
2007). The core molecular mechanism of MOMP revealed here
provides a framework by which these regulatory mechanisms
can be identified and evaluated. In addition, the series of assays
devised here will be useful in the elucidation of the molecular
mechanisms by which other proteins and small molecules that
interact with Bcl-2 family proteins regulate apoptosis.
EXPERIMENTAL PROCEDURES
Protein Purification and Labeling
For expression and purification of the mutants of Bax with a single cysteine at
position 126 or 134, the corresponding cDNAs were transferred from the ap-
propriate retroviral vectors (Annis et al., 2005) into the IMPACT bacterial ex-
pression system (New England Biolabs), generating plasmids pMAC1731
and pMAC1736, respectively. Recombinant Bax was purified as described
previously (Yethon et al., 2003). Plasmids encoding His-Bid G94E
(pMAC2121) and His-Bid C30S (pMAC2118) were generated from the His-
Bid-encoding plasmid (pMAC1446) with Quikchange mutagenesis (Strata-
gene). His-Bid, tBid, C30S Bid, C126S Bid, the caspase-8 cleavage products,
and the corresponding G94E proteins were purified as described (Dlugosz
et al., 2006). Details of the purification of the other proteins, labeling reactions,
and fluorescence spectroscopy are provided in the Supplemental Data.
For the liposome permeabilization assays in Figure 1, 1 mg mitochondrial-
like lipids (0.46 mg egg phosphatidylcholine, 0.25 mg egg phosphatidyletha-
nolamine, 0.11 mg bovine liver phophatidylinositol, 0.10 mg 18:1 phosphati-
dylserine, and 0.08 mg cardiolipin) were hydrated in Buffer A (10 mM HEPES
[pH 7], 135 mM KCl, 1 mM MgCl2). For incorporation of MPTS, (0.75 mM, Anas-
pec #85725), 3 kDa fluorescent dextran (0.5 mg, Invitrogen #D3305), APC,
(0.4 mg, Cyanotech #100300), and BPE, (0.4 mg, Cyanotech #100301), they
were added to lipid films in 1 ml of Buffer. Liposomes were formed by extru-
sion, and unincorporated dyes and fluorescent molecules were removed by
gel filtration over a 12 ml Sepharose CL-2B column equilibrated with Buffer
A. After incubation with the indicated proteins in a 300 ml reaction, released flu-
orophores were separated from permeabilized liposomes by gel filtration with
3 ml Sepharose CL-2B column and collecting 300 uL fractions. CHAPS was
added to all fractions to 1% in order to eliminate self-quenching in unlysed
liposomes before quantification with fluorescence.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and six
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(08)01439-6.
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